share_log

Replimune Group Analyst Ratings

Replimune Group Analyst Ratings

Replimune Group分析师评级
Benzinga Analyst Ratings ·  2023/01/05 04:41
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
01/05/2023 128.57% EF Hutton → $60 Initiates Coverage On → Buy
12/12/2022 166.67% BMO Capital $40 → $70 Maintains Outperform
12/07/2022 29.52% SVB Leerink $30 → $34 Maintains Outperform
11/04/2022 82.86% HC Wainwright & Co. $60 → $48 Maintains Buy
10/14/2022 52.38% BMO Capital $30 → $40 Maintains Outperform
10/03/2022 14.29% SVB Leerink $37 → $30 Maintains Outperform
08/16/2022 63.81% Piper Sandler $44 → $43 Maintains Overweight
08/05/2022 40.95% SVB Leerink $48 → $37 Maintains Outperform
05/24/2022 98.1% Wedbush $59 → $52 Maintains Outperform
05/20/2022 82.86% SVB Leerink $49 → $48 Maintains Outperform
04/04/2022 48.57% JP Morgan $47 → $39 Maintains Overweight
03/18/2022 14.29% BMO Capital $51 → $30 Maintains Outperform
11/19/2021 98.1% Piper Sandler → $52 Initiates Coverage On → Overweight
08/23/2021 86.67% SVB Leerink $55 → $49 Maintains Outperform
08/09/2021 109.52% SVB Leerink $56 → $55 Maintains Outperform
02/05/2021 128.57% HC Wainwright & Co. $58 → $60 Maintains Buy
02/04/2021 113.33% SVB Leerink $57 → $56 Maintains Outperform
11/17/2020 128.57% BTIG → $60 Initiates Coverage On → Buy
11/10/2020 120.95% HC Wainwright & Co. $54 → $58 Maintains Buy
11/06/2020 117.14% BMO Capital $51 → $57 Maintains Outperform
10/15/2020 94.29% BMO Capital $40 → $51 Maintains Outperform
10/15/2020 105.71% HC Wainwright & Co. $25 → $54 Upgrades Neutral → Buy
10/15/2020 67.62% SVB Leerink $27 → $44 Maintains Outperform
08/07/2020 2.86% SVB Leerink $25 → $27 Maintains Outperform
07/01/2020 -4.76% HC Wainwright & Co. → $25 Downgrades Buy → Neutral
06/04/2020 -4.76% HC Wainwright & Co. $24 → $25 Maintains Buy
05/05/2020 -20% Barclays → $21 Initiates Coverage On → Overweight
01/21/2020 -8.57% HC Wainwright & Co. $26 → $24 Maintains Buy
09/04/2019 -23.81% Roth Capital → $20 Initiates Coverage On → Buy
07/23/2019 6.67% Chardan Capital → $28 Initiates Coverage On → Buy
07/12/2019 -0.95% JP Morgan $27 → $26 Upgrades Neutral → Overweight
07/08/2019 -0.95% HC Wainwright & Co. → $26 Initiates Coverage On → Buy
04/25/2019 -8.57% Wedbush → $24 Initiates Coverage On → Outperform
01/23/2019 — JP Morgan Downgrades Overweight → Neutral
08/14/2018 18.1% BMO Capital → $31 Initiates Coverage On → Outperform
08/14/2018 -0.95% JP Morgan → $26 Initiates Coverage On → Overweight
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
01/05/2023 128.57% EF Hutton → $60 开始承保 →购买
12/12/2022 166.67% 蒙特利尔银行资本 $40 → $70 维护 跑赢大盘
12/07/2022 29.52% SVB Leerink $30 → $34 维护 跑赢大盘
11/04/2022 82.86% HC Wainwright公司 $60 → $48 维护 买
10/14/2022 52.38% 蒙特利尔银行资本 $30 → $40 维护 跑赢大盘
10/03/2022 14.29% SVB Leerink $37 → $30 维护 跑赢大盘
08/16/2022 63.81% 派珀·桑德勒 $44 → $43 维护 超重
08/05/2022 40.95% SVB Leerink $48 → $37 维护 跑赢大盘
05/24/2022 98.1% 韦德布什 $59 → $52 维护 跑赢大盘
05/20/2022 82.86% SVB Leerink $49 → $48 维护 跑赢大盘
04/04/2022 48.57% 摩根大通 $47 → $39 维护 超重
03/18/2022 14.29% 蒙特利尔银行资本 $51 → $30 维护 跑赢大盘
11/19/2021 98.1% 派珀·桑德勒 → $52 开始承保 →超重
08/23/2021 86.67% SVB Leerink $55 → $49 维护 跑赢大盘
08/09/2021 109.52% SVB Leerink $56 → $55 维护 跑赢大盘
02/05/2021 128.57% HC Wainwright公司 $58 → $60 维护 买
02/04/2021 113.33% SVB Leerink $57 → $56 维护 跑赢大盘
11/17/2020 128.57% BTIG → $60 开始承保 →购买
11/10/2020 120.95% HC Wainwright公司 $54 → $58 维护 买
11/06/2020 117.14% 蒙特利尔银行资本 $51 → $57 维护 跑赢大盘
10/15/2020 94.29% 蒙特利尔银行资本 $40 → $51 维护 跑赢大盘
10/15/2020 105.71% HC Wainwright公司 $25 → $54 升级 中性→购买
10/15/2020 67.62% SVB Leerink $27 → $44 维护 跑赢大盘
08/07/2020 2.86% SVB Leerink $25 → $27 维护 跑赢大盘
07/01/2020 -4.76% HC Wainwright公司 → $25 评级下调 购买→中性
06/04/2020 -4.76% HC Wainwright公司 $24 → $25 维护 买
05/05/2020 -20% 巴克莱 → $21 开始承保 →超重
01/21/2020 -8.57% HC Wainwright公司 $26 → $24 维护 买
09/04/2019 -23.81% 罗斯资本 → $20 开始承保 →购买
07/23/2019 6.67% 查尔丹资本 → $28 开始承保 →购买
07/12/2019 -0.95% 摩根大通 $27 → $26 升级 中性→超重
07/08/2019 -0.95% HC Wainwright公司 → $26 开始承保 →购买
04/25/2019 -8.57% 韦德布什 → $24 开始承保 →跑赢大盘
01/23/2019 — 摩根大通 评级下调 超重→中性
08/14/2018 18.1% 蒙特利尔银行资本 → $31 开始承保 →跑赢大盘
08/14/2018 -0.95% 摩根大通 → $26 开始承保 →超重

What is the target price for Replimune Group (REPL)?

Replimune Group(REPL)的目标价是多少？

The latest price target for Replimune Group (NASDAQ: REPL) was reported by EF Hutton on January 5, 2023. The analyst firm set a price target for $60.00 expecting REPL to rise to within 12 months (a possible 128.57% upside). 12 analyst firms have reported ratings in the last year.

复制集团(纳斯达克：REPL)的最新目标价是由EF Hutton于2023年1月5日报道的。这家分析公司将目标价定为60美元，预计每股收益将在12个月内升至(可能上涨128.57%)。去年有12家分析公司公布了评级。

What is the most recent analyst rating for Replimune Group (REPL)?

Replimune Group(REPL)的最新分析师评级是多少？

The latest analyst rating for Replimune Group (NASDAQ: REPL) was provided by EF Hutton, and Replimune Group initiated their buy rating.

复制集团(纳斯达克代码：REPL)的最新分析师评级由EF Hutton提供，复制集团启动了他们的买入评级。

When is the next analyst rating going to be posted or updated for Replimune Group (REPL)?

Replimune Group(REPL)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on January 5, 2023 so you should expect the next rating to be made available sometime around January 5, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Replimune Group的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Replimune Group的上一次评级是在2023年1月5日提交的，因此您应该预计下一次评级将在2024年1月5日左右提供。

Is the Analyst Rating Replimune Group (REPL) correct?

分析师评级Replimune Group(REPL)正确吗？

While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a initiated with a price target of $0.00 to $60.00. The current price Replimune Group (REPL) is trading at is $26.25, which is within the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Replimune Group(REPL)评级是以0.00美元至60.00美元的目标价启动的。Replimune Group(Replimune Group)目前的交易价格为26.25美元，在分析师的预测范围内。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发